Ceribell is headquartered in Mountain View, CA. Ceribell is focused on making EEG widely available, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizures. The Ceribell EEG System received FDA 510(k) clearance in 2017 and is commercially available in the United States.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/26/18 | $35,000,000 | Series B |
LivaNova Optimas Capital Partners Fund  The Rise Fund UCB | undisclosed |
| 04/29/21 | $53,000,000 | Series C |
Longitude Capital RA Capital Red Tree Venture Captial Redmile Group The Rise Fund | undisclosed |
